Tom Schoenherr
Fortuna: 5 M $ al 31/08/2026
Fortuna: 5 M $ al 31/08/2026
Tom Schoenherr is Chief Executive Officer-Diagnostics at Tempus AI, Inc. since 2026.
From 2017 to 2025, Mr. Schoenherr was Chief Executive Officer at Ambry Genetics Corp.
from 2021 to 2025.
Education includes undergraduate studies at Michigan State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TEMPUS AI, INC. CLASS A 0,04 % | 25/09/2026 | 76.740 ( 0,04 % ) | 5 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TEMPUS AI, INC. | Corporate Officer/Principal | 01/02/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Ambry Genetics Corp.
Ambry Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Provides genetic testing services | Director Ejecutivo | 01/01/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambry Genetics Corp.
Ambry Genetics Corp. Miscellaneous Commercial ServicesCommercial Services Provides genetic testing services | Commercial Services |
Tempus AI, Inc.
Tempus AI, Inc. Packaged SoftwareTechnology Services Develops AI platform for clinical and molecular data testing | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.